Previous Close | 0.1800 |
Open | 0.1800 |
Bid | 0.0000 |
Ask | 0.6100 |
Strike | 260.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.1800 - 0.1800 |
Contract Range | N/A |
Volume | |
Open Interest | 166 |
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.